Sofinnova Investments, Inc. Pharvaris N.V. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Pharvaris N.V. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 601,534 shares of PHVS stock, worth $12.9 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
601,534
Previous 584,672
2.88%
Holding current value
$12.9 Million
Previous $13.5 Million
16.31%
% of portfolio
0.63%
Previous 0.79%
Shares
5 transactions
Others Institutions Holding PHVS
# of Institutions
36Shares Held
37.8MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$162 Million4.48% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.29MShares$92.3 Million54.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$92.2 Million45.57% of portfolio
-
Viking Global Investors LP3.65MShares$78.5 Million0.27% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$73 Million7.0% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $726M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...